History
Company History
From founding in 2009 to a decade and a half of clinical and pharmaceutical development.
2009
Company founded
Better Cann Pharmaceutical is established to pursue clinical and pharmaceutical development of cannabinoid-based medicine.
2009+
Development of proprietary genetics
Long-term selection and stabilization of proprietary biological source genetics begins.
2010s
Early patient treatment experience
Accumulation of real-world treatment experience across complex medical conditions.
2010s
Multi-center clinical research
Participation in human clinical research, including children with treatment-resistant epilepsy at major Israeli medical centers.
—
Product development milestones
Development of medical formulations, oils, extracts, and therapeutic products from controlled source material.
—
International partnership expansion
Development of a strategy for clinical, licensing, and development partnerships across markets.
Today
Current research and development
Ongoing pharmaceutical development, quality work, and expansion of the biological source platform.